Research Paper Volume 13, Issue 6 pp 9085—9107

Nidogen-1 expression is associated with overall survival and temozolomide sensitivity in low-grade glioma patients

NID1 expression correlates with overall survival of LGG patients. (A, B) Kaplan-Meier survival curves show overall survival of low- and high-NID1-expressing LGG and GBM patients from the UALCAN database. (C, D) Kaplan-Meier survival curves show overall survival of low- and high-NID1-expressing LGG and GBM patients from the GEPIA database. HR refers to hazard ratio. (E, F) Kaplan-Meier survival curves show overall survival of low- and high-NID1-expressing LGG and GBM patients from the TCGA database. Note: Blue represents low NID1 expression; red represents high NID1 expression.

Figure 8. NID1 expression correlates with overall survival of LGG patients. (A, B) Kaplan-Meier survival curves show overall survival of low- and high-NID1-expressing LGG and GBM patients from the UALCAN database. (C, D) Kaplan-Meier survival curves show overall survival of low- and high-NID1-expressing LGG and GBM patients from the GEPIA database. HR refers to hazard ratio. (E, F) Kaplan-Meier survival curves show overall survival of low- and high-NID1-expressing LGG and GBM patients from the TCGA database. Note: Blue represents low NID1 expression; red represents high NID1 expression.